• Archives of neurology · Nov 2008

    Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.

    • Rohit Bakshi, Mohit Neema, Brian C Healy, Zsuzsanna Liptak, Rebecca A Betensky, Guy J Buckle, Susan A Gauthier, James Stankiewicz, Dominik Meier, Svetlana Egorova, Ashish Arora, Zachary D Guss, Bonnie Glanz, Samia J Khoury, Charles R G Guttmann, and Howard L Weiner.
    • Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. rbakshi@bwh.harvard.edu
    • Arch. Neurol. 2008 Nov 1; 65 (11): 1449-53.

    BackgroundIndividual magnetic resonance imaging (MRI) disease severity measures, such as atrophy or lesions, show weak relationships to clinical status in patients with multiple sclerosis (MS).ObjectiveTo combine MS-MRI measures of disease severity into a composite score.DesignRetrospective analysis of prospectively collected data.SettingCommunity-based and referral subspecialty clinic in an academic hospital.PatientsA total of 103 patients with MS, with a mean (SD) Expanded Disability Status Scale (EDSS) score of 3.3 (2.2), of whom 62 (60.2%) had the relapsing-remitting, 33 (32.0%) the secondary progressive, and 8 (7.8%) the primary progressive form.Main Outcome MeasuresBrain MRI measures included baseline T2 hyperintense (T2LV) and T1 hypointense (T1LV) lesion volume and brain parenchymal fraction (BPF), a marker of global atrophy. The ratio of T1LV to T2LV (T1:T2) assessed lesion severity. A Magnetic Resonance Disease Severity Scale (MRDSS) score, on a continuous scale from 0 to 10, was derived for each patient using T2LV, BPF, and T1:T2.ResultsThe MRDSS score averaged 5.1 (SD, 2.6). Baseline MRI and EDSS correlations were moderate for BPF, T1:T2, and MRDSS and weak for T2LV. The MRDSS showed a larger effect size than the individual MRI components in distinguishing patients with the relapsing-remitting form from those with the secondary progressive form. Models containing either T2LV or MRDSS were significantly associated with disability progression during the mean (SD) 3.2 (0.3)-year observation period, when adjusting for baseline EDSS score.ConclusionCombining brain MRI lesion and atrophy measures can predict MS clinical progression and provides the basis for developing an MRI-based continuous scale as a marker of MS disease severity.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…